期刊文献+

氟伐他汀对兔动脉粥样硬化斑块炎症的影响 被引量:1

Infuence of fluvastatin on plaque inflammation and Monocyte Chemoattractant Protein-1 expression in rabbit
下载PDF
导出
摘要 目的观察氟伐他汀对兔动脉粥样硬化斑块炎症和单核细胞趋化蛋白-1(MCP-1)的影响。方法将24只雄性新西兰大白兔随机分为对照组、单纯高脂组和氟伐他汀组,每组8只。对照组饲予常规颗粒饲料,单纯高脂组饲予高胆固醇饲料(1%胆固醇+5%猪油),氟伐他汀组饲予高胆固醇饲料+氟伐他汀,共饲养4个月。免疫组化染色观察斑块内巨噬细胞和MCP-1的变化,并应用RT-PCR检测MCP-1基因表达情况,同时测定血清TC、TG、LDL-C水平。结果氟伐他汀组的TC、LDL-C较单纯高脂组明显降低(P均<0.01),免疫组化显示氟伐他汀组的巨噬细胞阳性面积较单纯高脂组明显减低(P<0.01),斑块内MCP-1阳性面积也明显减低(P<0.01),RT-PCR显示氟伐他汀组的MCP-1/GAPDH的mRNA表达较单纯高脂组明显减低(P<0.01)。结论氟伐他汀可以抑制单核细胞浸润,减轻血管壁的炎症反应,其中降低MCP-1的表达可能是其重要机制之一。 Objective It is to observe the influence of fluvastatin on plaque inflammation and Monocyte Chemoattractant Protein 1 (MCP- 1) expression in rabbit. Methods Twenty-four male New Zealand white rabbits were randomly and equally assigned to 3 groups: control group ( n = 8), fed with normal diet; high-cholesterol group ( n = 8), fed with high- cholesterol diet alone; fluvastatin group (n = 8), fed with high-cholesterol diet and treated with fluvastatin; they were fed for 4 months. The levels of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL- C) were measured. And the changes of macrophage and MCP 1 were observed by immunohistochemical staining; The MCP - 1 mRNA was analyzed by RT - PCR. Results The levels of TC and LDL- C in fluvastatin group was significantly decreased than that in high-cholesterol group (P 〈 0.01 ). Immunohistochemical analysis showed much less stain in macrophage and MCP-1 in fluvastatin group than in high-cholesterol group (P〈0.01). The mRNA expressions of MCP- 1 were significantly decreased in fluvastatin group than that in high-cholesterol group (P〈0.01). Conclusion Fluvastatin can inhibit infiltration of macrophage, prevent early vascular inflammatory response of atherosclerosis and stabilize the process of atheroselerosis. Fluvastatin can reduce the expression of MCP- 1 probably is on of the acted mechanism.
出处 《现代中西医结合杂志》 CAS 2009年第3期248-250,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 动脉粥样硬化 单核细胞趋化蛋白-1 氟伐他汀 atherosclerosis Monocyte Chemoattractant Protein 1 fluvastatin
  • 相关文献

参考文献6

  • 1Viles-Gonzalez JF,Fuster V,Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis[ J ]. Curr Mol Med, 2006,6(5) :489 - 499
  • 2Aiello RJ,Bourassa P -AK, Lindsey S, et al. Monocyte chemoat tractant protein 1 accelerates atherosclerosis in apolipoprotein E-deficient mice[J]. Arterioscler Thromb Vasc Biol, 1999,19 (6) 1518 - 1525
  • 3Kim WJ ,Chereshnev l,Gazdoiu M,et al. MCP 1 deficiency is associated with reduced intinal hyperplasia after arterial injury[J]. Biochem Biophys Res Commun, 2003,310(3) :936-942
  • 4Inoue S, Egashira K, Ni W, etal. Ami-monocyte chemoattractant protein - 1 gene therapy limits progression and destabilization of established atheroslerosis in apolipoprotein E Knockout mice[J ]. Circulation,2002,106:2700-2706
  • 5仲琳,张运,陈文强,刘少荣,刘文波.单核细胞趋化蛋白-1与动脉粥样硬化斑块不稳定关系的临床研究——附25例检测报告[J].新医学,2005,36(1):18-19. 被引量:4
  • 6Jawahar L, Mehta, Jiawei Chen, et al. Lectin-like, oxidized low density lipoprotein receptor-1 (LOX - 1 ) : A critical player in the development of atheroselerosis and related dimrders[J]. Cardiovascular Research, 2006,69 ( 1 ) : 36 - 45

二级参考文献10

  • 1赵强,陈国伟.不稳定型心绞痛患者血清基质金属蛋白酶水平的临床意义——附45例检测报告[J].新医学,2004,35(8):461-463. 被引量:15
  • 2Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105 (9) : 1135-1143.
  • 3Davies ,MJ. Pathophysiology of acute coronary syndromes. Heart, 2000, 83(3) : 361-366.
  • 4Kim WJ, Chereshnev I, Gazdoiu M, et al. MCP-I deficiency is associated with reduced intimal hyperplasia after arterial injury. Biochem Biophys Res Commun, 2003, 310 (3) : 936-942.
  • 5Werle M, Schmal U, Hanna K, et al. MCP-I induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res, 2002, 56 (2) : 284-292.
  • 6Hoffman M, Blum A, Baruch R, et al. Leukocytes and coronary, heart disease. Atherosclerosis, 2004, 172 ( 1 ) : 1- 6.
  • 7de Lemos JA, Morroco DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patient with acute coronary sundromes. Circulation, 2003, 107(5) : 690- 695.
  • 8Davies ,MJ. Pathophysiology, of acute coronary syndromes. Heart, 2000, 83(3) : 361-366.
  • 9de Lemos JA, Morroco DA, Sabatine MS, et al. Association between plasma levels of monocyte ehemoattractant protein-1 and long-term clinical outcomes in patient with acute coronary sundromes. Circulation, 2003, 107(5) : 690- 695.
  • 10许文亮,郭新贵,徐延路,林宪如,何涛.冠心病患者血浆胆固醇与内皮素-1 C-反应蛋白及血小板可溶性P选择素相关性研究──附56例报告[J].新医学,2004,35(6):330-331. 被引量:25

共引文献3

同被引文献4

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部